This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. DNA plasmid vaccines have shown excellent safety and tolerability and are capable of eliciting T-cell responses in mice and nonhuman primates, and in clinical trials HIV related.
Showing the most recent 10 out of 515 publications